Oncology Devices Market Set for Robust Expansion, with AI Innovations and Advancements in Radiation Therapy Techniques
January 22, 2024 21:18 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global oncology devices market is...
Anti-Cancer Monoclonal Antibodies Market to Reach $95.99 billion by 2028, with Asia Pacific Emerging as Fastest-Growing Region
January 22, 2024 21:08 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The Anti-Cancer Monoclonal Antibodies (MAbs)...
Arvinas Appoints Jared Freedberg as General Counsel
January 16, 2024 17:01 ET
|
Arvinas Inc.
NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Asia Breast Cancer Screening Market Analysis Report 2023-2028: With a Focus on Improving Healthcare Outcomes, China is Poised to Make Significant Strides in Screening and Prevention
January 16, 2024 04:58 ET
|
Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "Asia Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Blackford and See-Mode Partner to Bring AI Breast and Thyroid Detection Software to the Blackford Platform
January 10, 2024 16:30 ET
|
Blackford
Blackford and See-Mode Partner to Add AI Breast and Thyroid Detection Software to the Blackford Platform
Breast Biopsy Market Set to Achieve US$ 3.8 Billion in Revenue by 2033, Report by Persistence Market Research
January 09, 2024 12:10 ET
|
Persistence Market Research
New York, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Breast biopsy is a medical procedure involving the removal of a sample of breast tissue for diagnostic examination. It is a crucial step in the early...
BRCA Tests Market Regulatory, Reimbursement and Forecasts to 2033
January 09, 2024 11:03 ET
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering....
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024 10:25 ET
|
FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
January 08, 2024 08:12 ET
|
Olema Oncology
OP-3136 demonstrated potent anti-tumor activity alone and in combination with both palazestrant and CDK4/6 inhibitors in preclinical ER+ breast cancer models Initiating IND-enabling studies with goal...
Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024 16:01 ET
|
Olema Oncology
SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...